EFPIA Highlights Europe ‘Lessons’ As Japan Ponders Policies
This article was originally published in PharmAsia News
Executive Summary
EFPIA remains cautious over moves in Japan towards a formal health technology assessment system and possible changes to the reimbursement pricing system, calling again for the maintenance of an environment conducive to pharma innovation and pointing to lessons from its experience in Europe.